Recomienda este artículo a tus amigos:
Risk / Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 - Developments in Cardiovascular Medicine J Morganroth Softcover reprint of the original 1st ed. 1989 edition
Risk / Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 - Developments in Cardiovascular Medicine
J Morganroth
The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agents.
298 pages, biography
| Medios de comunicación | Libros Paperback Book (Libro con tapa blanda y lomo encolado) |
| Publicado | 10 de octubre de 2011 |
| ISBN13 | 9781461288886 |
| Editores | Springer-Verlag New York Inc. |
| Páginas | 298 |
| Dimensiones | 234 × 154 × 23 mm · 490 g |
| Lengua | Inglés |
| Editor | Moore, E. Neil |
| Editor | Morganroth, J. |
Mas por J Morganroth
Mostrar todoMere med samme udgiver
Ver todo de J Morganroth ( Ej. Paperback Book )